ArticleFrontiers in pharmacology2023

Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis.

Gengwei Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.